Top compounds associated with response to TANK


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA masitinib GDSC1000 pan-cancer AAC -0.1 0.002
mRNA KIN001-102 GDSC1000 pan-cancer AAC -0.093 0.002
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.002
mRNA phenformin GDSC1000 pan-cancer AAC -0.095 0.002
mRNA Bortezomib gCSI pan-cancer AAC -0.18 0.003
mRNA SGC0946 GDSC1000 pan-cancer AAC 0.11 0.003
mRNA Rapamycin CTRPv2 pan-cancer AAC 0.1 0.003
mRNA decitabine CTRPv2 pan-cancer AAC -0.081 0.003
mRNA CX-5461 GDSC1000 pan-cancer AAC -0.095 0.003
Download CSV